首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
10-酯基高喜树碱的全合成及抗肿瘤活性研究   总被引:2,自引:0,他引:2  
以2,8-二氧-3-乙基-6,6-亚乙二氧基-2,3,5,6,7,8-六氢-3-羟基吡喃(5,4-c)中氮茚为起始原料, 经五步反应得到高喜树碱, 羟甲基化后与一系列酸成酯合成了6个10-酯基高喜树碱, 并利用1H NMR, MS及元素分析对其结构进行了表征. 采用经典的噻唑兰(Thiazoly blue tetrazolium bromide, MTT)法测定了其体外抗肿瘤活性, 活性测试结果表明3个化合物具有比阳性对照药拓扑替康增强的活性.  相似文献   

2.
A new series of mollugin-1,2,3-triazole derivatives were synthesized using a copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition reaction of corresponding O-propargylated mollugin with aryl azides. All the compounds were evaluated for their cytotoxicity on five human cancer cell lines (HL-60, A549, SMMC-7721, SW480, and MCF-7) using MTS assays. Among the synthesized series, most of them showed cytotoxicity and most of all, compounds 14 and 17 exhibited significant cytotoxicity of all five cancer cell lines.  相似文献   

3.
喹唑啉及其衍生物作为重要的药效团,具有广谱的抗肿瘤生物活性,一直是药物化学研究的热点。本文围绕近年来6-酰胺类、卤代类、醚类、与7-位成环类、杂环类等喹唑啉衍生物的合成及其抗肿瘤活性作用机制研究进行概述,以期为活性更高、毒性更小的新型抗肿瘤化合物的设计合成提供参考。  相似文献   

4.
A series of capecitabine derivatives with a Boc group at the N4-position was synthesized and their in vitro antitumor activities against HepG2(liver hepatocellular carcinoma) were primarily evaluated. Some compounds were chosen for further evaluation of their in vivo efficacy on nude mice xenografted human hepatoma HepG2. The results showed that compounds 3 and 6 had considerable in vivo activity against HepG2, with tumor growth inhibition rates of 70% and 64% on day 21, respectively, and 56% and 55% on day 35, respectively, which are roughly comparable to capecitabine(74% and 59% on days 21 and 35, respectively).  相似文献   

5.
为了寻找抗肿瘤活性化合物,以前期研究的含一个氨基酸结构单元的膦酸酯衍生物为基础,设计合成了15个二肽类膦酸酯衍生物(Ⅲa-Ⅲo).采用溴化噻唑蓝四氮唑(MTT)法进行体外抗肿瘤活性测试.结果表明:该类化合物对人肺癌细胞(A-549)、人胃癌细胞(SGC-7901))和人食管癌细胞(EC-109)有潜在增殖抑制作用.其中...  相似文献   

6.
设计合成了一类新型金诺芬衍生物, 采用核磁共振波谱(NMR)和高分辨质谱(HRMS)确认了其结构. 以目标化合物处理肿瘤细胞后, 采用四氮唑蓝盐(MTS)法检测细胞增殖情况, 用流式细胞仪检测细胞凋亡情况, 采用蛋白质免疫印迹(Western blot)法检测总的泛素化蛋白(Ub-Prs)、 K48 位链接多聚泛素化蛋白以及蛋白酶体外源性特异性底物(GFPu)的表达情况. 结果表明, 金诺芬衍生物可通过抑制蛋白酶体功能来发挥抗肿瘤效果.  相似文献   

7.
为寻找提高氟喹诺酮肿瘤活的有效结构修饰策略,左氧氟沙星(3)的衍生物(S)-(-)-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-[1,4]噁嗪并[2,3,4-ij]-喹啉-7(4H)-酮-6-甲醛(5)与饶丹宁类(2a-2l)通过Claisen-Schmid缩合反应构建了饶丹宁甲叉基取代左氧氟沙星衍...  相似文献   

8.
In this paper, we described the synthesis of 2-aminothiazole sublibrary containing methyl, bromo, phenyl or butylidene at 4- or/and 5-position of its core. All target compounds were evaluated for their antitumor activities against human lung cancer cell line H1299 and human glioma cell line SHG-44. Among the compounds screened, 4,5,6,7-tetrahydrobenzo[d]thiazole(26b) exhibited the most potent antitumor activities with IC50 values of 4.89 and 4.03 μmol/L against the two tested cell lines, respectively. Preliminary structure-activity relationship(SAR) studies of these compound were subsequently investigated.  相似文献   

9.
甘草次酸衍生物的合成及其抗癌活性   总被引:7,自引:0,他引:7  
设计合成了6种甘草次酸衍生物,用元素分析、波谱分析鉴定了它们的结构,并比较了它们的体内、体外抗癌活性,均表现出较好的活性,尤其是化合物Ⅰa,Ⅰb口服效果比盐酸氮芥还好,表现出甘草次酸对氮芥有明显的增效应用。  相似文献   

10.
A series of new glycoside derivatives of quinizarin were synthesized and characterized by NMR and IR spectrometry, and in vitro antitumor activity of some of these derivatives was evaluated against the mouse leukaemia P388 and the human leukaemia HL-60 cell lines by the standard MTT assay. They were proven to possess moderate antitumor activity.  相似文献   

11.
为了从喹唑啉衍生物中寻找高活性的抗肿瘤分子,以2-氨基苯甲酰胺为原料,经过三氟乙酰化、环化、氯代以及偶联反应等,合成了21个2-三氟甲基喹唑啉类化合物,并通过1H NMR、13C NMR、19F NMR进行结构确证。采用四唑盐(MTT)法评价目标化合物的体外抗肿瘤活性,结果表明,部分所合成的喹唑啉衍生物对人前列腺癌细胞(PC3、LNCaP)、人慢性髓系白血病细胞(K562)、宫颈癌细胞(Hela)以及人肺癌细胞(A549)具有抗增殖活性,其中活性较好的化合物5a和5b在5μmol/L时对LNCaP细胞增殖的抑制活性分别为61.7%、62.8%。此外N-甲基化产物5a和5b的体外抗肿瘤活性较原型化合物(4a和4b)显著提高,这为该类化合物的深入研究提供了参考依据。  相似文献   

12.
为了寻找高效低毒的抗肿瘤药物,设计并合成新型的1,3位取代酞嗪酮类化合物.采用噻唑蓝(MTT)法对目标化合物在MCF-7(人乳腺癌细胞)、PC-3(人前列腺癌细胞)、SW-620(人结肠癌细胞)和HGC-27(人胃癌细胞)四种人类癌细胞的抗增殖活性进行评价.结果显示大部分化合物具有较好的抗增殖活性.其中,2-(4-(4-溴苯基)-1-氧代酞嗪-2(1H)-基)-N-(2-氟苯基)乙酰胺(5g)对MCF-7细胞的抗增殖活性较好,IC50值为6.01μmol/L,为抗肿瘤药物的研究提供了思路.  相似文献   

13.
氨基酸5-氟尿嘧啶酯类衍生物的合成及其抗肿瘤活性研究   总被引:4,自引:1,他引:3  
以N-保护的氨基酸钾盐与1-(ω-溴丙基)-5-氟尿嘧啶和1-(ω-溴丁基)-5-氟尿嘧啶反应,制备了18种氨基酸的ω-(N1-5-氟尿嘧啶基)-丙醇酯和丁醇酯的盐酸盐,并确定了它们的结构。动物试验的初步结果表明,酪氨酸、苯丙氨酸的3-(N1-5-氟尿嘧啶基)-丙醇酯盐酸盐对小鼠艾氏腹水癌的抑制率分别为88.1%和86.7%。  相似文献   

14.
利用席夫碱与亚磷酸酯反应, 合成了新型O,O'-二烷基-α-(6-甲氧苯并噻唑-2-基氨基)-4-氟苯基膦酸酯化合物, 结构经元素分析, IR, 1H NMR, 13C NMR和X单晶衍射确认. X单晶衍射测试结果表明: 化合物3d分子属于四面体晶系, 空间群I4(1)/a, a=2.1055(3) nm, b=2.1055(3) nm, c=2.0521(5) nm, α=90.00°, β=90.00°, γ=90.00°, V=0.9098(3) nm3, Z=16, Dc=1.321 mg/m3, =0.250 mm-1, F(000)=3808. 化合物还存在着1个分子内氢键[N(2)—H(2)…O(1)]. 生物测定表明化合物3f在20 g/mL浓度下对PC3细胞的抑制率为84.3%.  相似文献   

15.
吲哚是一种自然界中广泛存在的化合物,具有抗肿瘤、抗氧化、抗菌等生物活性。在吲哚3-位引入不同的取代基,进行结构的修饰与改造一直是药物研究的热点。本文归纳总结了近年来相关的文献,对吡唑及吡唑啉类、二唑及三唑类、与2-位成环类等不同杂环取代的3-取代吲哚衍生物的抗肿瘤活性进行系统性的综述,以期为高活性抗肿瘤药物的研发提供一定的理论基础。  相似文献   

16.
吲哚马来酰亚胺类化合物的合成及其抗肿瘤活性   总被引:1,自引:0,他引:1  
为寻找具有抗肿瘤活性的新化合物, 设计合成吲哚马来酰亚胺类化合物, 并评价其体外抗肿瘤活性. 以吲哚与2-氯乙酰胺为起始原料, 经取代、缩合等反应合成了单吲哚马来酰亚胺衍生物5a~5t, 以5-硝基吲哚和不同的N-(3-氯丙基)叔胺经取代、还原、缩合等反应得到了双吲哚马来酰亚胺衍生物9a~9f. 共合成了26个未见文献报道的新化合物, 其结构经质谱、元素分析和核磁共振氢谱确证. 采用MTT法, 测试了目标化合物对肿瘤细胞株HL60, ECA-109, A549, SMMC-7721和PC-3的增殖抑制活性, 结果表明部分化合物对所测肿瘤细胞株均显示一定的抑制作用.  相似文献   

17.
A series of Olaparib derivatives was synthesized, and their structures were confirmed by 1H NMR, MS and elemental analysis. Their antitumor activities on breast cancer susceptbility gene 1/2(BRCA1/2)-deficient cancer cell lines including HCC1937, Capan-1 and MDA-MB-436 were evaluated. The antitumor activity of compound Olaparib-1 was better than the positive control Olaparib in BRCA1-deficient cell line HCC1937.  相似文献   

18.
放线菌素D新类似物的设计、合成与体外抗肿瘤活性   总被引:1,自引:0,他引:1  
为了提高临床抗肿瘤药物放线菌素D(AMD)的抗肿瘤效果和治疗指数,在AMD构效关系研究基础上,设计全合成了包括9个新类似物在内的两类共13个AMD类似物.保持环肽2位D-Val不变,环肽5位分别用Sar,D-Me-Leu和Me-Ile等氨基酸替换以改变侧链基团长度,合成了类似物8b~8e;以环肽2位D-Phe替换的低毒性类似物[D-Phe2]2AMD为基础,在环肽5位进行氨基酸替换,改变侧链基团长度和空间指向,并引入芳香族氨基酸等,合成了类似物8f~8m.优化了类似物的合成中的反应条件,提高了五肽环化产率,避免了消旋产物的生成.所有类似物经[α]D,1HNMR和高分辨质谱表征后,采用MTT法进行了体外抗肿瘤活性筛选,结果表明,保留环肽2位D-Val及延长5位氨基酸侧链基团能显著提高类似物的抗肿瘤活性,而2位D-Phe替换后类似物的抗肿瘤活性普遍下降.  相似文献   

19.
在三乙胺存在下,溴乙酰葡萄糖与Ge-132反应,得到了Ge-132的葡萄糖苷衍生物(包括2,4-二-O-乙酰基-1,3,6-三-O-羧乙基锗基-β-D-葡萄糖苷,I及Ⅱ),并对其进行了结构,物理化学性质及抑制肿瘤活性等方面的实验。  相似文献   

20.
We designed and synthesized a 7-azaindole derivative(TH1082), which was characterized by 1^H NMR and 13^C-NMR. We investigated its antitumor effects on human melanoma A375 cells, human liver cancer SMMC cells and human breast cancer MCF-7 cells in vitro via 3-(4,5-dimethyldiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay and also explored the mechanism of antiproliferation of them. The results show that TH1082 significantly inhibited the proliferation of these cells to different extent. The IC50 values for A375 cells, SMMC cells and MCF-7 cells were 25.38, 48.70 and 76.94 μg/mL at 24 h, respectively. To observe cell morphological changes, acridine orange/ethidium bromide(AO/EB) staining and Hoechest33342/Pl staining were carried out. These results indicate that TH1082 could induced the apoptosis of A375 cells. The apoptotic rates were (9.5±2.09)%, (18.9±2.25)% and (39.5±2.02)%(5, 10 and 20 μg/mL) for A375, SMMC and MCF-7 cell lines, respectively. Further, we determined the activities of caspase-3 and caspase-9 in A375 cells treated with TH1082 at different concentrations(0, 5, 10 and 20 μg/mL) or Z-VAD-FMK(20 μmol/L), a pan-caspase inhibitor for 24 h. The results show that TH1082 activated caspase-3 and caspase-9, and the activation could be blocked by Z-VAD-FMK. Taken together, these findings indicate that TH 1082 could inhibit the proliferation ofA375 cells via activating caspase-3 and caspase-9.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号